Sponsor:
Dartmouth-Hitchcock Medical Center
Code:
NCT07612254
Conditions
Breast Cancer Recurrent
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Reirradiation
Brief summary:
Conditions
Breast Cancer Recurrent
Study ID
NCT07612254
Start date
Jun 3, 2026
Status verified date
Nov, 2026
Completion date
Apr, 2033
Anticipated
Primary completion date
Apr 28, 2032
Anticipated
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: aPBI Re-irradiation
Interventions
Reirradiation
Primary outcome measure
Locations
Dartmouth-Hitchcock Medical Center
Recruiting
Lebanon, New Hampshire, United States, 03756
Contacts
Principal Investigator:
Lesley A Jarvis
Sponsor
Dartmouth-Hitchcock Medical Center
Last update posted
Nov 16, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.